Alkermes, an Irish drugmaker with operations in the U.S.,is cutting 160 jobs to lower expenses after losing $54 million last quarter, according to Boston Business Journal.

Biogen CEO Michel Vounatsos told CNBC he remains "confident" the company's Alzheimer's drug will receive FDA approval.

House Speaker Nancy Pelosi's drug pricing plan was approved by the House Ways and Means Committee Oct. 22 and is now ready for a full House vote, according to CNBC.

Centennial, Colo-based Centura Health opened a new retail pharmacy on its hospital campus in Kansas, according to The Garden City Telegram.

The FDA sent a warning letter to a Naples, Fla.-based vitamin and supplements store for falsely claiming its cannabis products could treat conditions such as Autism and Alzheimer's.

Adderall is in short supply, according to the FDA Drug Shortages website.

Drug Topics compiled a list of the top 10 states to live and work as a pharmacist by compiling data from the Bureau of Labor Statistics, WalletHub and U.S. News and World Report.

Akebia Therapeutics, a small Cambridge, Mass.-based drugmaker, has filed a lawsuit against CMS, claiming Medicare's denial to cover its anemia drug violates the law, according to STAT.

In the first full quarter since its launch in May 2019, Novartis' $2.1 million gene therapy Zolgensma has beat analyst's sales expectations, according to STAT. 

Consumers have sued several Zantac manufacturers for allegedly failing to disclose that the heartburn drug can produce small amounts of a possible carcinogen, according to STAT.